• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿司匹林用于青少年关节炎的治疗。

Aspirin in the treatment of juvenile arthritis.

作者信息

Baum J

出版信息

Am J Med. 1983 Jun 14;74(6A):10-5. doi: 10.1016/0002-9343(83)90523-5.

DOI:10.1016/0002-9343(83)90523-5
PMID:6344620
Abstract

Aspirin can be more closely controlled than other nonsteroidal anti-inflammatory drugs because serum salicylate levels can be measured. Dosages of 80 to 100 mg/kg per day usually lead to the desired serum salicylate levels of 20 to 25 mg/dl. Gastric irritation, the most frequent cause for cessation of aspirin therapy, is significantly reduced by the use of enteric-coated aspirin. At the onset of aspirin therapy in children, there is frequently moderate elevation of SGOT and SGPT liver enzyme levels. With continued treatment these levels usually fall into the range of mild elevations. Although these children with arthritis often take high doses of aspirin for years, Reye's syndrome is virtually never seen.

摘要

与其他非甾体抗炎药相比,阿司匹林的用量可以得到更严格的控制,因为可以检测血清水杨酸水平。每天80至100毫克/千克的剂量通常会使血清水杨酸水平达到理想的20至25毫克/分升。使用肠溶阿司匹林可显著减少阿司匹林治疗中最常见的停药原因——胃部刺激。在儿童开始使用阿司匹林治疗时,血清谷草转氨酶(SGOT)和谷丙转氨酶(SGPT)水平常常会出现中度升高。持续治疗后,这些水平通常会降至轻度升高的范围。尽管这些患有关节炎的儿童常常多年服用高剂量的阿司匹林,但几乎从未出现过瑞氏综合征。

相似文献

1
Aspirin in the treatment of juvenile arthritis.阿司匹林用于青少年关节炎的治疗。
Am J Med. 1983 Jun 14;74(6A):10-5. doi: 10.1016/0002-9343(83)90523-5.
2
Aspirin-induced hepatotoxicity and its effect on juvenile rheumatoid arthritis.阿司匹林诱发的肝毒性及其对青少年类风湿性关节炎的影响。
Am J Dis Child. 1977 Jun;131(6):659-63. doi: 10.1001/archpedi.1977.02120190053012.
3
Aspirin-induced hepatotoxicity in juvenile rheumatoid arthritis. A prospective study.青少年类风湿关节炎中阿司匹林诱导的肝毒性。一项前瞻性研究。
Arthritis Rheum. 1975 Jul-Aug;18(4):347-52. doi: 10.1002/art.1780180409.
4
Salicylate therapy in juvenile rheumatoid arthritis. Dose, serum level, and toxicity.青少年类风湿关节炎的水杨酸盐治疗。剂量、血清水平及毒性。
Am J Dis Child. 1980 May;134(5):461-3. doi: 10.1001/archpedi.1980.02130170011005.
5
Chronic salicylate administration in juvenile rheumatoid arthritis: aspirin "hepatitis" and its clinical significance.青少年类风湿关节炎中慢性水杨酸盐给药:阿司匹林“肝炎”及其临床意义。
Pediatrics. 1978 Nov;62(5 Pt 2 Suppl):916-25.
6
Dosage of salicylates for children with juvenile rheumatoid arthritis. A preliminary report.青少年类风湿性关节炎患儿的水杨酸盐剂量。初步报告。
Scand J Rheumatol. 1975;4(4):250-2. doi: 10.3109/03009747509165266.
7
Salicylate hepatotoxicity in patients with juvenile rheumatoid arthritis.青少年类风湿关节炎患者的水杨酸盐肝毒性
Arthritis Rheum. 1973 Jan-Feb;16(1):1-9. doi: 10.1002/art.1780160102.
8
Serum salicylate levels in a breast fed infant.一名母乳喂养婴儿的血清水杨酸水平。
Ann Rheum Dis. 1987 Aug;46(8):638-9. doi: 10.1136/ard.46.8.638.
9
Correlations between transaminase concentrations and serum salicylate concentration in juvenile rheumatoid arthritis.青少年类风湿关节炎中转氨酶浓度与血清水杨酸酯浓度的相关性。
Arthritis Rheum. 1976 Jan-Feb;19(1):115-8. doi: 10.1002/art.1780190121.
10
Children with juvenile rheumatoid arthritis treated with salicylates for 15 days, with daily serum salicylate determinations.患有青少年类风湿性关节炎的儿童接受水杨酸盐治疗15天,并每日测定血清水杨酸盐含量。
Scand J Rheumatol. 1976;5(4):251-2. doi: 10.3109/03009747609099915.

引用本文的文献

1
Paediatric Rheumatology Fails to Meet Current Benchmarks, a Call for Health Equity for Children Living with Juvenile Idiopathic Arthritis, Using Digital Health Technologies.儿科风湿病学未能达到当前标准,呼吁利用数字健康技术实现儿童青少年特发性关节炎患者的健康公平。
Curr Rheumatol Rep. 2024 Jun;26(6):214-221. doi: 10.1007/s11926-024-01145-w. Epub 2024 Mar 11.
2
Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.新生儿和儿童的抗血栓治疗:抗血栓治疗和血栓预防,第 9 版:美国胸科医师学会基于证据的临床实践指南。
Chest. 2012 Feb;141(2 Suppl):e737S-e801S. doi: 10.1378/chest.11-2308.